This event results in the expression of the BCR-ABL1 fusion gene, which codes for a constitutively active tyrosine kinase responsible for the transformation of a HSC into a CML stem cell, and thence to a clonal myeloproliferative disease. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.